LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas
Clinical trial NCT05663125 · UNKNOWN
Trial details
- NCT number
- NCT05663125
- Sponsor
- Beijing Tiantan Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-01
- Primary completion
- 2023-12-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.